BRIACELL THERAPEUTICS CORP. Proceeds from (Repayments of) Related Party Debt
BRIACELL THERAPEUTICS CORP. (BCTX) had Proceeds from (Repayments of) Related Party Debt of $175.00 thousand as of 2023-12-20, per its 10-K filed 2024-10-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2024-10-29
- BRIACELL THERAPEUTICS CORP. proceeds from (repayments of) related party debt for fiscal 2023 was $125.00K.
| Period end | Proceeds from (Repayments of) Related Party Debt | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|
| 2023-12-20 | $175.00K 10-K · filed 2024-10-29 | |
| 2023-08-01 | $175.00K 10-K · filed 2024-10-29 | |
| 2023-07-31 | $125.00K 10-Q · filed 2024-06-14 | $125.00K 10-K · filed 2024-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |